scholarly journals Resource utilization and disaggregated cost analysis of bariatric surgery in the Australian public healthcare system

Author(s):  
Qing Xia ◽  
Julie A. Campbell ◽  
Hasnat Ahmad ◽  
Barbara de Graaff ◽  
Lei Si ◽  
...  
2012 ◽  
Vol 56 (1) ◽  
pp. 33-38 ◽  
Author(s):  
Cristina Khawali ◽  
Marcos Bosi Ferraz ◽  
Maria Tereza Zanella ◽  
Sandra R. G. Ferreira

OBJECTIVES: To assess QoL of obese patients in the Brazilian public healthcare system, before and after bariatric surgery, and to determine the appropriateness of the Moorehead-Ardelt Questionnaire II (M-A-QoLQII) compared with the Short-Form Health Survey (SF-36). SUBJECTS AND METHODS: Forty-one severe obese patients in a waiting-list, and 84 patients who underwent bariatric surgery were included. Correlations were tested and reliability determined by the Cronbach's coefficient. RESULTS: BMI differed between the pre- and post-surgery groups (52.3 ± 8.3 kg/m² vs. 32.5 ± 6.4 kg/m², p < 0.001). The latter showed better scores in the SF-36 domains than in the pre-surgery. SF-36 and M-A-QoLQII categories were correlated (r = 0.53, 0.49 and 0.47, for vitality, mental health, and general health domains, p < 0.001). In the logistic regression, age, previous BMI, and loss of excess weight were associated with functional capacity. CONCLUSIONS: The outcomes of bariatric surgery obtained in a Brazilian public healthcare center were successful. M-A-QoLII represents a useful tool to assess surgery outcomes, including QoL.


2016 ◽  
Vol 27 (2) ◽  
pp. 536-540 ◽  
Author(s):  
Irineu Rasera ◽  
Alexandre Luque ◽  
Silvio Mauro Junqueira ◽  
Níssia Capello Brasil ◽  
Priscila Caldeira Andrade

2021 ◽  
Author(s):  
Arlene M. D'Silva ◽  
Hugo Sampaio ◽  
Didu Sanduni Thamarasa Kariyawasam ◽  
David Mowat ◽  
Jacqui Russell ◽  
...  

Bioethica ◽  
2020 ◽  
Vol 6 (2) ◽  
pp. 30
Author(s):  
Nikolaos Kolisis (Νικόλαος Κολίσης)

The invention of CRISPR technology and its current and potential applications have been a subject of controversy among scientists, philosophers and legal theorists. After taking under consideration the current discussion concerning the use of CRISPR for editing human genome the article treats the question of a wider offer of CRISPR-based therapies from a Public Healthcare system and proposes method for a fair and financially sustainable way for adopting the new possibilities this new tool has to offer.


Sign in / Sign up

Export Citation Format

Share Document